{"id":"W3161615669","doi":"10.1038/s41467-021-23152-6","title":"Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity","year":2021,"lang":"en","type":"article","venue":"Nature Communications","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Center for Scientific Review; Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of General Medical Sciences; National Institute on Aging; Michigan Technology Tri-Corridor; National Cancer Institute; University of Toronto; National Institutes of Health; U.S. Department of Health and Human Services; Michigan Economic Development Corporation; National Institute of Diabetes and Digestive and Kidney Diseases; Office of Science; University of Michigan; Leukemia and Lymphoma Society; National Heart, Lung, and Blood Institute; Argonne National Laboratory; U.S. Department of Energy","keywords":"Druggability; Chemistry; Histone methyltransferase; Small molecule; Drug discovery; Leukemia; Cell biology; Computational biology; Cancer research; Biology; Biochemistry; Epigenetics; Gene; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001296488,0.000101684,0.0001825743,0.00006425974,0.00005306345,0.000007081288,0.0003480387,0.000220085,0.000004147497],"category_scores_gemma":[0.0001637409,0.00009428589,0.00007811523,0.0003119872,0.000196282,0.0000150568,0.0001434838,0.0003469416,3.920141e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003150195,"about_ca_system_score_gemma":0.0001992846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005630481,"about_ca_topic_score_gemma":0.001670292,"domain_scores_codex":[0.9992554,0.0001297518,0.0002126457,0.0001787399,0.0001246106,0.00009885422],"domain_scores_gemma":[0.9984324,0.00005577359,0.0001145996,0.001189267,0.0001816687,0.00002629212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00004558951,0.0003060901,0.008636608,0.0000315232,0.00003941004,9.206456e-7,0.00004601874,0.00002256754,0.9892377,0.000711178,0.0005146454,0.0004076932],"study_design_scores_gemma":[0.0004927818,0.00006514625,0.01166748,0.00006033452,0.00001811681,0.000004707013,0.00006683125,0.0000344215,0.9782383,0.00001718499,0.009228932,0.000105771],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912287,0.005429636,0.0004039773,0.001380269,0.00006318773,0.0001452488,0.00006040235,0.00000583259,0.001282758],"genre_scores_gemma":[0.9962762,0.001310386,0.001920067,0.00006548847,0.00001984402,0.00001744941,0.0002017094,0.00001245719,0.0001764013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01099946,"threshold_uncertainty_score":0.3844867,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01001106999974645,"score_gpt":0.2772316053937022,"score_spread":0.2672205353939557,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}